SE9301422D0 - Method and means for inhibiting posterior capsule opacification - Google Patents

Method and means for inhibiting posterior capsule opacification

Info

Publication number
SE9301422D0
SE9301422D0 SE19939301422A SE9301422A SE9301422D0 SE 9301422 D0 SE9301422 D0 SE 9301422D0 SE 19939301422 A SE19939301422 A SE 19939301422A SE 9301422 A SE9301422 A SE 9301422A SE 9301422 D0 SE9301422 D0 SE 9301422D0
Authority
SE
Sweden
Prior art keywords
pct
posterior capsule
capsule opacification
sec
date
Prior art date
Application number
SE19939301422A
Other languages
English (en)
Inventor
*Maansson Per
*Rolfsen Wenche
*Wickstroem Kerstin
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE19939301422A priority Critical patent/SE9301422D0/sv
Publication of SE9301422D0 publication Critical patent/SE9301422D0/sv
Priority to DE69422707T priority patent/DE69422707T2/de
Priority to DK94914668T priority patent/DK0696917T3/da
Priority to CA002161697A priority patent/CA2161697C/en
Priority to JP6524162A priority patent/JPH08509494A/ja
Priority to PCT/SE1994/000371 priority patent/WO1994025020A1/en
Priority to AT94914668T priority patent/ATE188872T1/de
Priority to US08/553,529 priority patent/US5576345A/en
Priority to EP94914668A priority patent/EP0696917B1/en
Priority to ES94914668T priority patent/ES2143546T3/es
Priority to PT94914668T priority patent/PT696917E/pt
Priority to AU66941/94A priority patent/AU6694194A/en
Priority to GR20000400842T priority patent/GR3033149T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
SE19939301422A 1993-04-28 1993-04-28 Method and means for inhibiting posterior capsule opacification SE9301422D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE19939301422A SE9301422D0 (sv) 1993-04-28 1993-04-28 Method and means for inhibiting posterior capsule opacification
AU66941/94A AU6694194A (en) 1993-04-28 1994-04-26 Method and means for inhibiting posterior capsule opacification
JP6524162A JPH08509494A (ja) 1993-04-28 1994-04-26 後嚢の混濁化を予防するための方法及び手段
DK94914668T DK0696917T3 (da) 1993-04-28 1994-04-26 Fremgangsmåde til forhindring af uklarhed i bagerste linsekapsel
CA002161697A CA2161697C (en) 1993-04-28 1994-04-26 Method and means for inhibiting posterior capsule opacification
DE69422707T DE69422707T2 (de) 1993-04-28 1994-04-26 Verfahren zur verhinderung der trübung der hinteren linsenkapsel
PCT/SE1994/000371 WO1994025020A1 (en) 1993-04-28 1994-04-26 Method and means for inhibiting posterior capsule opacification
AT94914668T ATE188872T1 (de) 1993-04-28 1994-04-26 Verfahren zur verhinderung der trübung der hinteren linsenkapsel
US08/553,529 US5576345A (en) 1993-04-28 1994-04-26 Method and means for inhibiting posterior capsule opacification
EP94914668A EP0696917B1 (en) 1993-04-28 1994-04-26 Method for inhibiting posterior capsule opacification
ES94914668T ES2143546T3 (es) 1993-04-28 1994-04-26 Metodo para inhibir la opacificacion de la capsula posterior.
PT94914668T PT696917E (pt) 1993-04-28 1994-04-26 Metodo destinado a evitar a opacificacao da capsula posterior
GR20000400842T GR3033149T3 (en) 1993-04-28 2000-04-04 Method and means for inhibiting posterior capsule opacification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301422A SE9301422D0 (sv) 1993-04-28 1993-04-28 Method and means for inhibiting posterior capsule opacification

Publications (1)

Publication Number Publication Date
SE9301422D0 true SE9301422D0 (sv) 1993-04-28

Family

ID=20389737

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939301422A SE9301422D0 (sv) 1993-04-28 1993-04-28 Method and means for inhibiting posterior capsule opacification

Country Status (13)

Country Link
US (1) US5576345A (sv)
EP (1) EP0696917B1 (sv)
JP (1) JPH08509494A (sv)
AT (1) ATE188872T1 (sv)
AU (1) AU6694194A (sv)
CA (1) CA2161697C (sv)
DE (1) DE69422707T2 (sv)
DK (1) DK0696917T3 (sv)
ES (1) ES2143546T3 (sv)
GR (1) GR3033149T3 (sv)
PT (1) PT696917E (sv)
SE (1) SE9301422D0 (sv)
WO (1) WO1994025020A1 (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
ES2388248T3 (es) 1997-03-31 2012-10-11 Boston Scientific Scimed Limited Forma de dosificación que comprende taxol en forma cristalina
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
CA2208924A1 (en) * 1997-07-09 1999-01-09 Hyal Pharmaceutical Corporation Sparing paclitaxel by the use of hyaluronan
US6027531A (en) 1997-10-14 2000-02-22 Tassignon; Marie-Joseb. R. Intraocular lens and method for preventing secondary opacification
US6491721B2 (en) 1998-04-15 2002-12-10 Alcon Manufacturing, Ltd. Toric intraocular lens material
US6482230B1 (en) 1998-04-15 2002-11-19 Alcon Manufacturing, Ltd. Lens epithelial cell growth assay for intraocular lens materials
DE69900475T2 (de) * 1998-04-15 2002-05-08 Alcon Lab Inc Zweiteilige intraokulare linse und verfahren zu ihrer herstellung
US6416550B2 (en) 1998-04-15 2002-07-09 Alcon Manufacturing, Ltd. Method of selecting an intraocular lens material
US6455318B1 (en) 1998-04-15 2002-09-24 Alcon Manufacturing, Ltd. Collagen IV adhesion assay for intraocular lens materials
CA2317441C (en) 1998-04-15 2007-12-18 Alcon Laboratories, Inc. Intraocular lens coating compositions
DE19955836C1 (de) 1999-11-19 2001-05-17 Norbert Hampp Ophthalmologisches Implantat
DE60131773T2 (de) 2000-09-06 2008-04-10 Alcon Inc. Beschichtungsmittel mit veränderbarer klebrigkeit für augenimplantate
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US20030157161A1 (en) * 2001-05-01 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
CA2445763A1 (en) * 2001-05-01 2002-11-07 Angiotech Pharmaceuticals Inc. Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
US6703466B1 (en) 2001-06-18 2004-03-09 Alcon, Inc. Foldable intraocular lens optics having a glassy surface
WO2003026744A1 (en) * 2001-09-25 2003-04-03 Alcon, Inc. The use of epothilones and analogs in conjunction with ophthalmic surgery
US20030194421A1 (en) * 2001-12-28 2003-10-16 Angiotech Pharmaceuticals, Inc. Treatment of uveitis
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US20040058899A1 (en) * 2002-09-25 2004-03-25 Klimko Peter G. Use of epothilones and analogs in conjunction with ophthalmic surgery
WO2004082542A2 (en) * 2003-03-17 2004-09-30 Pharmacia Groningen Bv New method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252319A (en) * 1990-06-12 1993-10-12 Insite Vision Incorporated Aminosteroids for ophthalmic use

Also Published As

Publication number Publication date
US5576345A (en) 1996-11-19
EP0696917B1 (en) 2000-01-19
PT696917E (pt) 2000-06-30
ATE188872T1 (de) 2000-02-15
AU6694194A (en) 1994-11-21
JPH08509494A (ja) 1996-10-08
ES2143546T3 (es) 2000-05-16
DK0696917T3 (da) 2000-06-26
CA2161697A1 (en) 1994-11-10
CA2161697C (en) 1998-11-10
DE69422707D1 (de) 2000-02-24
WO1994025020A1 (en) 1994-11-10
DE69422707T2 (de) 2000-08-03
GR3033149T3 (en) 2000-08-31
EP0696917A1 (en) 1996-02-21

Similar Documents

Publication Publication Date Title
SE9301422D0 (sv) Method and means for inhibiting posterior capsule opacification
EP0916320A3 (en) Intraocular lens and method for preventing secondary opacification
IL137245A0 (en) Intraocular lens implant with telescope support
WO2003039409B1 (en) Intraocular lens
DE69435264D1 (de) Akommodationsfähige Intraokularlinse
CA2317441A1 (en) Intraocular lens coating compositions
SE9303627D0 (sv) Method and means for prevention of cataract
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
WO2001035867A8 (de) Ophthalmologisches implantat
EA199900374A1 (ru) Ингибитор вторичной катаракты
MXPA03005922A (es) Metodo para tratar glaucoma ib.
MY128862A (en) "inhibition of polymerization of ethylenically unsaturated monomer"
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
WO2003093877A3 (en) Posterior chamber phakic lens
FR2701390B1 (fr) Perfectionnement aux haptiques d'un implant oculaire de chambre postérieure.
RU2004225C1 (ru) Способ имплантации искусственного хрусталика
UA10771A (uk) Спосіб профілактики післяопераційhих ускладhеhь після екстракції катаракти з імплаhтацією кришталика
RU94022801A (ru) Способ имплантации искусственного хрусталика глаза при отсутствии капсулы хрусталика
RU2000122736A (ru) Способ имплантации эластичного искусственного хрусталика
RU95120625A (ru) Способ экстракапсулярной экстракции катаракты с имплантацией заднекамерной иол из эластичного материала
RU93032282A (ru) Искусственный внутриглазной имплантат
RU97105639A (ru) Способ хирургического лечения катаракты, сочетанной с деструкцией стекловидного тела
RU98112503A (ru) Способ экстракции катаракты путем факоэмульсификации
RU97102446A (ru) Способ одномоментного хирургического лечения катаракты и отслойки сетчатки